THENATIONALPULSE (Pulse Wires) - FDA Reverses Rejection of Moderna MRNA Flu Vax, Will Now Review for Approval.
PULSE POINTSWHAT HAPPENED: The U.S. Food and Drug Administration (FDA) has reversed a prior decision from last week and will review Moderna’s flu vaccine for possible approval.WHO WAS INVOLVED: Moderna, the FDA, Dr. Vinay Prasad, and FDA Commissioner Dr. Marty Makary.WHEN & WHERE: February 18, 2026, United States.IMPACT: The potential approval could make the vaccine […] The post FDA Reverses Rejection of Moderna MRNA Flu Vax, Will Now Review for Approval. appeared first on The National Pulse .
PULSE POINTS WHAT HAPPENED: The U.S. Food and Drug Administration (FDA) has reversed a prior decision from last week and will review Moderna’s flu vaccine for possible approval. WHO WAS INVOLVED: Moderna, the FDA, Dr. Vinay Prasad, and FDA Commissioner Dr. Marty Makary. WHEN & WHERE: February 18, 2026, United States. IMPACT: The potential approval could make the vaccine available for older adults in the upcoming flu season. IN FULL Moderna has announced that the U.S. Food and Drug Administration (FDA ) has decided to review its flu vaccine, reversing its previous rejection from last week. The initial rejection cited flaws in Moderna’s research design, but subsequent discussions led the FDA to agree to reconsider. Regulators are now…Open